106 related articles for article (PubMed ID: 9792547)
1. Role for heparin-binding growth factors in glucose-induced vascular dysfunction.
Stephan CC; Chang KC; LeJeune W; Erichsen D; Bjercke RJ; Rege A; Biediger RJ; Kogan TP; Brock TA; Williamson JR; Tilton RG
Diabetes; 1998 Nov; 47(11):1771-8. PubMed ID: 9792547
[TBL] [Abstract][Full Text] [Related]
2. Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor.
Tilton RG; Kawamura T; Chang KC; Ido Y; Bjercke RJ; Stephan CC; Brock TA; Williamson JR
J Clin Invest; 1997 May; 99(9):2192-202. PubMed ID: 9151791
[TBL] [Abstract][Full Text] [Related]
3. Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment.
Dellian M; Witwer BP; Salehi HA; Yuan F; Jain RK
Am J Pathol; 1996 Jul; 149(1):59-71. PubMed ID: 8686763
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor and basic fibroblast growth factor differentially modulate early postnatal coronary angiogenesis.
Tomanek RJ; Sandra A; Zheng W; Brock T; Bjercke RJ; Holifield JS
Circ Res; 2001 Jun; 88(11):1135-41. PubMed ID: 11397779
[TBL] [Abstract][Full Text] [Related]
5. Vascular dysfunction induced by AGE is mediated by VEGF via mechanisms involving reactive oxygen species, guanylate cyclase, and protein kinase C.
Ido Y; Chang KC; Lejeune WS; Bjercke RJ; Reiser KM; Williamson JR; Tilton RG
Microcirculation; 2001 Aug; 8(4):251-63. PubMed ID: 11528533
[TBL] [Abstract][Full Text] [Related]
6. Suppression of VEGF-induced angiogenesis by the protein tyrosine kinase inhibitor, lavendustin A.
Hu DE; Fan TP
Br J Pharmacol; 1995 Jan; 114(2):262-8. PubMed ID: 7533611
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane.
Vriese AS; Tilton RG; Stephan CC; Lameire NH
J Am Soc Nephrol; 2001 Aug; 12(8):1734-1741. PubMed ID: 11461947
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by tranilast of vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF)-induced increase in vascular permeability in rats.
Isaji M; Miyata H; Ajisawa Y; Yoshimura N
Life Sci; 1998; 63(4):PL71-4. PubMed ID: 9698042
[TBL] [Abstract][Full Text] [Related]
9. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability.
Eliceiri BP; Paul R; Schwartzberg PL; Hood JD; Leng J; Cheresh DA
Mol Cell; 1999 Dec; 4(6):915-24. PubMed ID: 10635317
[TBL] [Abstract][Full Text] [Related]
10. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.
Gorski DH; Beckett MA; Jaskowiak NT; Calvin DP; Mauceri HJ; Salloum RM; Seetharam S; Koons A; Hari DM; Kufe DW; Weichselbaum RR
Cancer Res; 1999 Jul; 59(14):3374-8. PubMed ID: 10416597
[TBL] [Abstract][Full Text] [Related]
11. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.
Cornali E; Zietz C; Benelli R; Weninger W; Masiello L; Breier G; Tschachler E; Albini A; Stürzl M
Am J Pathol; 1996 Dec; 149(6):1851-69. PubMed ID: 8952523
[TBL] [Abstract][Full Text] [Related]
13. VEGF-initiated blood-retinal barrier breakdown in early diabetes.
Qaum T; Xu Q; Joussen AM; Clemens MW; Qin W; Miyamoto K; Hassessian H; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2408-13. PubMed ID: 11527957
[TBL] [Abstract][Full Text] [Related]
14. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF.
Cao R; Brakenhielm E; Wahlestedt C; Thyberg J; Cao Y
Proc Natl Acad Sci U S A; 2001 May; 98(11):6390-5. PubMed ID: 11344271
[TBL] [Abstract][Full Text] [Related]
15. The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies.
Kim KJ; Li B; Houck K; Winer J; Ferrara N
Growth Factors; 1992; 7(1):53-64. PubMed ID: 1380254
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.
Brekken RA; Overholser JP; Stastny VA; Waltenberger J; Minna JD; Thorpe PE
Cancer Res; 2000 Sep; 60(18):5117-24. PubMed ID: 11016638
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes.
Vriese AS; Tilton RG; Elger M; Stephan CC; Kriz W; Lameire NH
J Am Soc Nephrol; 2001 May; 12(5):993-1000. PubMed ID: 11316858
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO.
Fischer S; Clauss M; Wiesnet M; Renz D; Schaper W; Karliczek GF
Am J Physiol; 1999 Apr; 276(4):C812-20. PubMed ID: 10199811
[TBL] [Abstract][Full Text] [Related]
19. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF.
Tilton RG; Chang KC; LeJeune WS; Stephan CC; Brock TA; Williamson JR
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):689-96. PubMed ID: 10067972
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor.
Monsky WL; Fukumura D; Gohongi T; Ancukiewcz M; Weich HA; Torchilin VP; Yuan F; Jain RK
Cancer Res; 1999 Aug; 59(16):4129-35. PubMed ID: 10463618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
